Analysts expect Aurinia Pharmaceuticals Inc. to report revenue of 87.23 M for Q4 26, against a range of 84.32 M to 90.14 M. The most recent reported quarter, Q3 26, came in at 83.70 M, a 7.5% beat against the 77.89 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 59.87 M | 62.47 M | 70.01 M | 73.47 M | 77.11 M | 77.70 M | 83.22 M | 83.70 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 61.94 M | 60.08 M | 71.15 M | 72.92 M | 73.20 M | 83.32 M | 90.60 M | 83.99 M | 90.14 M | 91.89 M | 94.07 M | 102.17 M | 106.29 M | 101.36 M | 116.80 M | 123.98 M | |||||||||
| Low Estimate | 51.28 M | 54.50 M | 64.06 M | 59.74 M | 66.79 M | 75.92 M | 80.73 M | 71.80 M | 84.32 M | 79.17 M | 80.91 M | 92.42 M | 100.10 M | 89.29 M | 109.92 M | 114.21 M | |||||||||
| Consensus Estimate | 56.61 M | 57.29 M | 67.61 M | 66.33 M | 69.99 M | 79.62 M | 85.66 M | 77.89 M | 87.23 M | 85.53 M | 87.49 M | 97.30 M | 103.19 M | 95.33 M | 113.36 M | 119.10 M |
Analysts expect Aurinia Pharmaceuticals Inc. to report earnings per share of 0.20 for Q4 26, against a range of 0.19 to 0.21. The most recent reported quarter, Q3 26, came in at 0.23 , in line with the 0.23 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.01 | 0.16 | 0.16 | 0.23 | 1.53 | 0.25 | 0.28 | 0.23 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.02 | 0.11 | 0.17 | 0.16 | 0.25 | 0.20 | 0.26 | 0.25 | 0.21 | 0.19 | 0.23 | 0.24 | 0.52 | 0.20 | 0.29 | 0.27 | |||||||||
| Low Estimate | -0.02 | 0.09 | 0.15 | 0.14 | 0.21 | 0.18 | 0.24 | 0.21 | 0.19 | 0.17 | 0.19 | 0.20 | 0.44 | 0.18 | 0.25 | 0.23 | |||||||||
| Consensus Estimate | -0.02 | 0.10 | 0.16 | 0.15 | 0.23 | 0.19 | 0.25 | 0.23 | 0.20 | 0.18 | 0.21 | 0.22 | 0.48 | 0.19 | 0.27 | 0.25 |
Pull Wall Street consensus for Aurinia Pharmaceuticals Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AUPH&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AUPH", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AUPH&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();